By Sheila Plant, Ph.D., R.A.C., Assistant Director, Regulatory Strategy, US at Cato Research One revised draft FDA guidance, released from CBER, and two MAPPs, released from CDER, in May 2017, are posted. In addition, upcoming advisory committee meetings to be … Continue reading
The post New FDA Guidances for May 2017 appeared first on Ask Cato Research.